The shares of this small-cap firm, which is a fast-moving shopper healthcare group, are in focus within the day’s commerce, adopted by an open provide to amass it for Rs. 2,983 Crores.
Worth Motion
With a market capitalization of Rs 11,473 crore, the shares of Sanofi Shopper Healthcare India Ltd made a 52-week excessive of Rs 5,375.00 per share, down by 7.2 p.c from its present market worth of Rs 4,982.10 per share. The inventory has given a constructive return of three.08 p.c over the past six months.
Concerning the announcement
Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII, L.P. have made an open provide to buy as much as 59.88 lakh Sanofi Shopper Healthcare India Ltd’s fairness shares, representing 26 p.c for Rs 4,982.05 per share.
That is an all-cash bid of Rs 2,983.23 crore based mostly on full acceptance and is a part of a worldwide management transition after Sanofi agreed to promote Opella Healthcare SAS, which not directly holds a 60.40 p.c stake in Sanofi Shopper Healthcare India.
The interval of tender is from April 25 to Might 9, 2025, and the cost date is Might 26. After the deal, Clayton, Dubilier & Rice Fund XII, L.P. may have 50 p.c of Opal Bidco SAS, Sanofi 48%, and Bpifrance 2 p.c. All regulatory clearances are already in hand, and the transaction will create a world shopper healthcare chief headquartered in France.
Monetary Highlights
The corporate reported a consolidated income of Rs 171 crore in Q3 FY25, up by 6.8 p.c, from its Q3 FY24 income of Rs 160 crore. It posted a internet revenue of Rs 44 crore in Q3 FY25, down by 2.2 p.c, from its Q3 FY24 internet revenue of Rs 45 crore. It has a P/E of 57x, which is increased than the trade P/E ratio of 49.28x.
Concerning the Firm
Sanofi Shopper Healthcare India Restricted, which was included within the 12 months 2023 and has its headquarters situated in Mumbai, is a fast-moving shopper healthcare group and a subsidiary of Sanofi India Restricted. Its merchandise are marketed within the subject of allergy, ache care, and bodily well-being underneath manufacturers akin to Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. These are marketed by way of wholesalers, authorities companies, hospitals, pharmacies, and on-line platforms.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer will not be chargeable for any losses induced on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
